If you’re RhD-negative, whether you need anti-D after early pregnancy bleeding, miscarriage or abortion depends on how many weeks pregnant you are, what happened and whether treatment was medical or surgical. For “rh negative miscarriage” questions, there isn’t one worldwide rule: guidance has changed, and local protocols can differ.
What “rh negative miscarriage” guidance means
Anti-D immunoglobulin (also called Rh immune globulin; RhoGAM is a US brand) is intended to help prevent an RhD-negative person from becoming sensitized if RhD-positive fetal blood enters their circulation. Sensitization can matter in a future pregnancy. Anti-D does not treat a miscarriage or prevent one, and being RhD-negative is not itself a cause of pregnancy loss.
The recommendations are not uniform for early pregnancy. A 2025 systematic review by Kristina Gemzell-Danielsson and colleagues compared international guidance and research on first-trimester abortion. It found that guidance published from 2022 onward, including World Health Organization guidance, recommends against anti-D for first-trimester abortion, while many older guidelines recommended testing and anti-D even before 12 weeks. The authors describe the underlying evidence as limited and inconsistent. Their review highlights a disagreement in policy; it does not prove that one approach has the same effect in every setting or circumstance.
The American College of Obstetricians and Gynecologists issued a 2024 clinical practice update on Rh testing and anti-D after abortion or pregnancy loss before 12 weeks. Recommendations and local implementation can change, so ask your care team which current guideline they follow. A policy for abortion may not cover bleeding or miscarriage in the same way.
Why gestational age and treatment matter
One NHS Greater Glasgow and Clyde guideline, approved in September 2025, illustrates how a local protocol can draw distinctions that are important in practice. It says anti-D is not required for a complete miscarriage before 12 weeks or for miscarriage managed only with medication before 12 weeks. From 12 weeks, it recommends anti-D for miscarriage, including medical management. It also recommends anti-D after surgical management of miscarriage or manual vacuum aspiration, including before 12 weeks.
For a termination of pregnancy, that same Scottish guideline does not require anti-D for medical or surgical care up to 12 weeks; at 12 weeks or later, it recommends it. For threatened miscarriage with a viable pregnancy before 12 weeks, it says to consider anti-D when bleeding is recurrent, heavy or accompanied by significant abdominal pain. After 12 weeks, it recommends it.
These are local recommendations, not a universal rule for the whole UK or for other countries. They show why the words “early miscarriage” alone may not answer the question: the completed pregnancy week, bleeding pattern and whether a procedure is planned can change the recommendation. Medical and surgical abortion are also not treated differently in every guideline.
What to ask your care team
If you have RhD-negative blood and have had bleeding or a pregnancy loss, tell the clinician your blood group if you know it, how many weeks pregnant you were, and whether you had medication or a procedure. Ask whether your local guidance recommends anti-D for your specific event. Recommendations generally concern people who have not already developed immune anti-D antibodies; an antibody screen and your medical record help clinicians determine what applies.
When anti-D is recommended, guidance commonly says to give it as soon as possible, usually within 72 hours of the event. A Greater Glasgow and Clyde guideline notes that some protection may still be provided if it is given up to 10 days later. If more than 72 hours have passed, contact your care team promptly rather than assuming it is too late or that the same timing rule applies everywhere.
Because advice differs by region and can depend on the details of your care, a clinician or pregnancy-loss service can confirm the current local recommendation. This article cannot determine whether you personally need an injection.